Cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound
US9969699B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 7, 2015 |
| Grant date | May 15, 2018 |
| Priority date | — |
| Expiry date | Sep 7, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/71
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cancer cell proliferation inhibitor including at least one selected from compounds represented by Structural Formulae (1) to (8), wherein the cancer cell is at least one of a cancer cell overexpressing a wild-type epidermal growth factor receptor and a cancer cell expressing an epidermal growth factor receptor mutant vIII.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.